The scientist’s investigation covers issues in Colorectal cancer, Cancer, Internal medicine, Genetics and Oncology. The concepts of his Colorectal cancer study are interwoven with issues in Telomere, Mortality rate, Microsatellite instability and Pathology. His Cancer study integrates concerns from other disciplines, such as Body mass index, Germline mutation and Risk factor.
His study looks at the relationship between Internal medicine and topics such as Gastroenterology, which overlap with Colectomy and Young adult. Mark A. Jenkins has included themes like Hazard ratio, Penetrance, Adenomatous polyposis coli, Family history and CpG site in his Oncology study. His Lynch syndrome research is multidisciplinary, incorporating perspectives in MLH1, Gene mutation, MSH2, Endometrial cancer and MSH6.
His primary areas of study are Colorectal cancer, Internal medicine, Oncology, Cancer and Lynch syndrome. His research integrates issues of Genome-wide association study, Microsatellite instability and Pathology in his study of Colorectal cancer. Breast cancer, Family history, Odds ratio, Case-control study and Confidence interval are among the areas of Internal medicine where Mark A. Jenkins concentrates his study.
While the research belongs to areas of Oncology, Mark A. Jenkins spends his time largely on the problem of Hazard ratio, intersecting his research to questions surrounding Proportional hazards model and Surgery. His research in Cancer intersects with topics in Gastroenterology, MUTYH, Epidemiology and Risk factor. His Lynch syndrome research integrates issues from MLH1, Germline mutation, PMS2, Gene mutation and MSH2.
Mark A. Jenkins spends much of his time researching Colorectal cancer, Internal medicine, Oncology, Cancer and Lynch syndrome. The study incorporates disciplines such as Cancer research, Genome-wide association study, Epidemiology and Family history in addition to Colorectal cancer. He combines subjects such as Mendelian randomization and Microsatellite instability with his study of Internal medicine.
His Oncology research incorporates themes from Body mass index, Breast cancer, Cohort and Hazard ratio. His study in Cancer is interdisciplinary in nature, drawing from both Family medicine and Risk factor. He works mostly in the field of Lynch syndrome, limiting it down to topics relating to MSH6 and, in certain cases, PMS2.
Colorectal cancer, Internal medicine, Oncology, Genome-wide association study and Cancer are his primary areas of study. His studies in Colorectal cancer integrate themes in fields like Epidemiology, Case-control study, Incidence and Candidate gene. His Internal medicine study combines topics from a wide range of disciplines, such as Mendelian randomization and Microsatellite instability.
Mark A. Jenkins interconnects Genetic predisposition, Proportional hazards model, Hazard ratio, Breast cancer and Cohort in the investigation of issues within Oncology. The study incorporates disciplines such as Genetic association and Allele frequency in addition to Genome-wide association study. His Cancer research incorporates elements of Susceptibility locus and Family medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Leigha Senter;Mark Clendenning;Kaisa Sotamaa;Heather Hampel.
Validation of Questionnaire and Bronchial Hyperresponsiveness against Respiratory Physician Assessment in the Diagnosis of Asthma
Mark A Jenkins;Jane R Clarke;John B Carlin;Colin F Robertson.
International Journal of Epidemiology (1996)
Identification of Lynch syndrome among patients with colorectal cancer
Leticia Moreira;Francesc Balaguer;Noralane Lindor;Albert De La Chapelle.
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community
Trang Vu;Stephen Farish;Mark Jenkins;Heath Kelly.
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Satoru Yokoyama;Susan L. Woods;Glen M. Boyle;Lauren G. Aoude.
Dominant Negative ATM Mutations in Breast Cancer Families
Georgia Chenevix-Trench;Amanda B. Spurdle;Magtouf Gatei;Helena Kelly.
Journal of the National Cancer Institute (2002)
Identification of IL6R and chromosome 11q13.5 as risk loci for asthma
Manuel A Ferreira;Melanie C Matheson;David L Duffy;Guy B Marks.
The Lancet (2011)
Factors in childhood as predictors of asthma in adult life
Mark A Jenkins;John L Hopper;Glenn Bowes;John B Carlin.
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Laura Baglietto;Noralane M. Lindor;James G. Dowty;Darren M. White.
Journal of the National Cancer Institute (2010)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pål Møller;Toni T Seppälä;Inge Bernstein;Inge Bernstein;Elke Holinski-Feder.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: